|
MechanismAT III activators |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date07 Dec 2001 |
100 Clinical Results associated with Glaxo Wellcome Production SAS
0 Patents (Medical) associated with Glaxo Wellcome Production SAS
100 Deals associated with Glaxo Wellcome Production SAS
100 Translational Medicine associated with Glaxo Wellcome Production SAS